Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Series A, Series B, Growth
Geographical Focus
United States
Industries Focus
- Healthcare
- Digital Health
- Diagnostics
- Consumer Health
- Biopharma
- Tech-Enabled Services
- Devices
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2024
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building upon its track record at RH Capital. The firm focuses on early-stage companies addressing conditions that affect women directly, differently, and disproportionately, aiming to make healthcare more accessible, affordable, and equitable. Foreground Capital invests broadly across health segments, including biopharma, devices, diagnostics, digital health, tech-enabled services, and consumer health. The firm's investment strategy is guided by four core impact pillars: Transformative Innovation, Access, Affordability, and Systemic Change. These pillars drive meaningful improvements in healthcare outcomes for women while delivering competitive financial returns. Foreground Capital's leadership team brings over 50 years of combined experience across finance, clinical medicine, and venture capital, with a commitment to advancing women's health innovation. The firm has built one of the largest dedicated women's health portfolios in the world, investing in companies that are transforming healthcare for women across the United States. Foreground Capital continues to manage legacy funds RH Capital Fund I and II and launched Foreground Capital Fund III in July 2025. The firm is headquartered in San Francisco, California, with an office in Boston, Massachusetts. Foreground Capital is committed to diversity, with 90 percent of its portfolio companies led by women or people of color, and 95 percent having a woman on the board. The firm seeks to lead or co-lead Seed and Series A rounds and is also open to joining strong syndicates with co-investors. Foreground Capital's investment process involves a rigorous diligence process, assessing each opportunity for its alignment with the firm's impact pillars and potential for both financial and social returns. The firm is hands-on with its portfolio companies, offering support in strategy, fundraising, hiring, and other aspects of company building, leveraging its sector expertise in women's health and vast network in the space. Foreground Capital's commitment to women's health is both an issue of equity and one of the most exciting frontiers of biomedical science, aiming to reshape how healthcare serves women and address the many areas in women's health still looking for improved and new solutions.
Requirements
- Companies addressing conditions that affect women directly, differently, and disproportionately
- Early-stage companies in biopharma, devices, diagnostics, digital health, tech-enabled services, and consumer health
- Alignment with Foreground Capital's impact pillars: Transformative Innovation, Access, Affordability, and Systemic Change
- Potential for both financial and social returns
- Diverse leadership teams
- Focus on the U.S. market, with preference for a local lead if based outside the U.S.
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Millie
- Gesynta Pharma
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$14.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of Foreground Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim